Searched over 200M research papers for "cerebrovasc dis"
10 papers analyzed
These studies suggest cerebrovascular disease is linked to cognitive impairment, central nervous system infections, Alzheimer's disease, genetic factors, and gut microbes, with significant implications for diagnosis, treatment, and prevention.
20 papers analyzed
Cerebrovascular disease (CVD) encompasses a range of conditions that affect the blood vessels and blood supply to the brain, leading to significant morbidity and mortality. These conditions include ischemic stroke, hemorrhagic stroke, and other vascular abnormalities that can result in cognitive impairment and disability .
CVD is a major contributor to cognitive impairment and dementia. Various forms of vascular cognitive impairment (VCI) have been identified, including arteriosclerotic dementia, multi-infarct dementia, and subcortical ischemic vascular dementia. Cognitive decline in CVD is often due to ischemic injury, which leads to the destruction of brain tissue. This process can result in significant loss of brain volume and is sometimes overdiagnosed in comparison to Alzheimer's disease (AD).
CVD and AD frequently coexist, particularly in older adults. Many patients with AD also exhibit cerebrovascular pathology, such as amyloid angiopathy and ischemic lesions. The interaction between CVD and AD can exacerbate cognitive decline, with CVD contributing to reduced blood flow and hypoperfusion in the brain, which in turn accelerates neurodegenerative processes .
CVD can also arise as a complication of central nervous system (CNS) infections. Infections can lead to vasculitis, vasospasm, thrombosis, and a hypercoagulable state, all of which can result in cerebral infarction. These vascular complications often have severe neurological outcomes, highlighting the importance of early diagnosis and treatment.
Genetic factors play a significant role in the development of CVD. Studies have shown that genetic predispositions, particularly those affecting lipid metabolism, can increase the risk of atherosclerosis and ischemic stroke. Understanding these genetic factors is crucial for developing targeted prevention and treatment strategies.
Fabry's disease (FD) is a genetic disorder that can lead to cerebrovascular complications. Patients with FD often experience recurrent strokes and other vascular events due to dilative arteriopathy, particularly in the vertebrobasilar circulation. These events are associated with a high recurrence rate and poor prognosis.
CVD in children, although less common than in adults, can result in significant long-term disability. Pediatric strokes can be ischemic or hemorrhagic, with ischemic strokes often leading to more residual disability despite better survival rates.
Emerging research highlights the role of gut microbiota in the development and progression of CVD. The gut-brain axis involves complex interactions between gut bacteria and brain health, influencing immune responses, intestinal barrier function, and microbial metabolites. These interactions offer potential therapeutic targets, such as dietary interventions and fecal bacterial transplantation, to mitigate CVD.
Cerebrovascular disease is a multifaceted condition with significant implications for cognitive health and overall neurological function. Understanding the mechanisms, genetic factors, and interactions with other diseases like Alzheimer's is crucial for developing effective prevention and treatment strategies. Ongoing research into the gut-brain axis and genetic predispositions offers promising avenues for future therapeutic interventions.
Most relevant research papers on this topic